ClinicalTrials.Veeva

Menu

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

K

Kreiskrankenhaus Dormagen

Status and phase

Completed
Phase 4

Conditions

Pain
Total Knee Arthroplasty

Treatments

Drug: Ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT01843153
sciatic block

Details and patient eligibility

About

The role of a sciatic block in addition to a femoral block remains controversial. The study addresses this topic by comparing a continuous block versus an injection on demand.

Enrollment

140 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for total knee arthroplasty

Exclusion criteria

  • failure to establish femoral and sciatic block
  • insufficient analgesic effect of the block
  • patient declines to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

140 participants in 2 patient groups

intermittent
Other group
Description:
injection of ropivacaine on demand
Treatment:
Drug: Ropivacaine
continuous
Other group
Description:
continuous ropivacaine infusion
Treatment:
Drug: Ropivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems